Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Monsanto Company    MON

Delayed Quote. Delayed  - 09/23 10:01:06 pm
103.5 USD   -0.67%
11:33a MONSANTO : Announces $1.6 Million Investment in Developing System to..
11:33a MONSANTO : Announces Global Licensing Agreement with Broad Institute..
07:48a MONSANTO : Program highlights US soy role on global scale
News SummaryMost relevantAll newsSector news 

Monsanto Company : Monsanto 2Q Net Up 19% On Strong US Selling Season

share with twitter share with LinkedIn share with facebook
share via e-mail
04/04/2012 | 07:40pm CEST

--Monsanto reports 2Q earnings jump 19%

--Warm winter helps drive sales

--Corn, soybean seed net sales both increase

(Updates with comments from executive, analysts.)

   By Ian Berry 

Monsanto Co. (MON) raised its earnings outlook for the year on strong demand for corn seed as U.S. farmers plan to plant a huge crop this spring.

The world's largest seed company said second-quarter earnings jumped 19% over a year ago, due in large part to its corn seed and traits business. Net sales in that business, which increased 17%, were buffeted by higher volumes and demand for higher-priced seeds, as well as unusually warm winter weather that fueled early seed shipments.

Federal forecasters last week projected U.S. farmers will plant the most corn acreage since 1937 to take advantage of continuing strong prices for the grain.

While Monsanto's earnings beat expectations, it was less clear to what extent the early sales in the second quarter will result in slower sales later in the year.

"How much of the great quarter is linked to timing, and how much is linked to actual performance in our business, it's difficult to measure at this point in time," Chief Financial Officer Pierre Courduroux said in a conference call with investors.

He said that earnings in the second half of the year would likely be flat versus a year ago. Still, the company was confident enough to raise its full-year earnings guidance to $3.49 to $3.54 a share, an increase of 10 cents a share.

Investor reaction was muted, as analysts said the new guidance was squarely within Wall Street expectations. Shares were recently down 1.2%, to $80.80 amid a broader market slump.

The St. Louis-based company reported increased sales across its top three businesses: corn, soybeans and agricultural productivity, which includes Roundup and other herbicides.

The company's improved seed sales are validating "a couple years of heavy lifting," Chairman and Chief Executive Hugh Grant said.

Monsanto in 2010 suffered through a backlash from farmers, who balked at the company's high initial price for its new premium corn seed, SmartStax. The problems were compounded by what was seen as a disappointing performance in the seed's first year, and the share price fell sharply.

Monsanto has since "made a conscious effort to address product choices and pricing to better connect" with customers, Grant said. Sales of the company's premium corn seed products so far this year are at the high end of expectations, he said.

Monsanto executives sound more humble than they did a couple years ago, said Mark Connelly, an analyst with CLSA. He added that Grant and other officials seem wary of building expectations too high. Rather than focusing on one particular seed for one particular region, it is emphasizing growth across geographic regions, including South America.

"Monsanto is not trying to be a one-hit wonder," Connelly said. "They are trying to convince you they have a long-term, sustainable growth story."

For the quarter ended Feb. 29, Monsanto, based in St. Louis, reported a profit of $1.21 billion, or $2.24 a share, up from a year-earlier profit of $1.02 billion, or $1.88 a share. Stripping out items like a settlement, earnings per share rose to $2.28 from $1.87 a year earlier.

Net sales rose 15%, to $4.75 billion. Analysts were looking for earnings of $2.12 a share on $4.53 billion in sales, according to a poll conducted by Thomson Reuters.

-By Ian Berry, Dow Jones Newswires; 312-750-4072; ian.berry@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
11:33a MONSANTO : Announces $1.6 Million Investment in Developing System to Help Agricu..
11:33a MONSANTO : Announces Global Licensing Agreement with Broad Institute on Key Geno..
07:48a MONSANTO : Program highlights US soy role on global scale
09/25 LETTER TO THE EDITOR : 'Compelling state interest' a sham
09/25 MONSANTO : Page G2 Segment-3
09/24 MONSANTO : Suspected dicamba damage begins to come into focus for Bootheel soy f..
09/24 MONSANTO : Secures Tech License from Broad Institute
09/24 BAYER : buys Monsanto for $66 bln
09/24 MONSANTO : Consolidation or domination?
09/23 Most Active Mix Cap Movers- Lockheed Martin, Monsanto Firm, Raytheon
More news
Sector news : Fishing & Farming - NEC
2015DJKUALA LUMPUR KEPONG BERHAD : Fiscal 4th-Quarter Net Profit Rises 9.1% -- Update
2015DJKUALA LUMPUR KEPONG BERHAD : Fiscal 4th-Quarter Net Profit Rises 9.1%
2015DJCHAROEN POKPHAND FOODS PUBLIC : Thai Business Empire Grapples With Global Hurdle..
2015DJCHAROEN POKPHAND FOODS PUBLIC : Thai Business Empire Grapples With Global Hurdle..
2015DJKUALA LUMPUR KEPONG BERHAD : 3rd-Quarter Net Profit Rises 15.6%
More sector news : Fishing & Farming - NEC
News from SeekingAlpha
09/23 Don't Be Fooled By Interest Rate Misdirection - Cramer's Mad Money (9/22/16)
09/23 Au Contraire The Economist; More Accounting Scandals Loom
09/21 Monsanto upgraded at J.P. Morgan
09/21 Bayer-Monsanto tie-up pilloried in Germany, U.S.
09/21 Presenting Apple's First Car
Financials ($)
Sales 2016 13 360 M
EBIT 2016 2 979 M
Net income 2016 1 439 M
Debt 2016 7 694 M
Yield 2016 2,05%
P/E ratio 2016 31,88
P/E ratio 2017 21,24
EV / Sales 2016 3,97x
EV / Sales 2017 3,81x
Capitalization 45 289 M
More Financials
Duration : Period :
Monsanto Company Technical Analysis Chart | MON | US61166W1018 | 4-Traders
Full-screen chart
Technical analysis trends MONSANTO COMPANY
Short TermMid-TermLong Term
Technical analysis
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 117 $
Spread / Average Target 13%
Consensus details
EPS Revisions
More Estimates Revisions
Hugh M. Grant Chairman & Chief Executive Officer
Brett D. Begemann President & Chief Operating Officer
Pierre C. Courduroux Chief Financial Officer & Senior Vice President
Robert T. Fraley Chief Technology Officer & Executive VP
Robert J. Stevens Lead Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
More Results